Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

TZT-1027 possesses additional antiangiogenic activity according to several recent studies

Oct. 20, 2000

New camptothecin derivative examined for safety, pharmacokinetics on various dosing schedules

Oct. 20, 2000

Cancer antigen discovery agreement signed by Genzyme Molecular Oncology and Purdue

Oct. 20, 2000

Antisense compound from Isis enters phase III clinical testing

Oct. 20, 2000

Positive phase IIa outcome reported for Xenova's XR-9576

Oct. 20, 2000

Lorus reports promising phase I/II results with anticancer drug; supply alliance formed

Oct. 19, 2000

Cellular experiments suggest potential role for new dimer in prostate cancer therapy

Oct. 19, 2000

New gelatinase inhibitors suppress endothelial cell proliferation and invasion

Oct. 19, 2000

IntraDose shows promise in treating liver metastases from colorectal cancer

Oct. 19, 2000

GnRH antagonists as a focus of research at Merck

Oct. 18, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...